CMH Stock Overview
A medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Chordate Medical Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 19.70 |
| 52 Week High | SEK 225.00 |
| 52 Week Low | SEK 20.00 |
| Beta | 0.91 |
| 11 Month Change | -52.64% |
| 3 Month Change | -35.62% |
| 1 Year Change | -79.90% |
| 33 Year Change | -97.55% |
| 5 Year Change | -95.74% |
| Change since IPO | -99.72% |
Recent News & Updates
Shareholder Returns
| CMH | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -12.1% | -4.0% | -3.6% |
| 1Y | -79.9% | -3.9% | 12.3% |
Return vs Industry: CMH underperformed the Swedish Medical Equipment industry which returned -3.9% over the past year.
Return vs Market: CMH underperformed the Swedish Market which returned 12.3% over the past year.
Price Volatility
| CMH volatility | |
|---|---|
| CMH Average Weekly Movement | 14.6% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: CMH's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: CMH's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 3 | Anders Weilandt | www.chordate.com |
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It offers Ozilia, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.
Chordate Medical Holding AB (publ) Fundamentals Summary
| CMH fundamental statistics | |
|---|---|
| Market cap | SEK 19.90m |
| Earnings (TTM) | -SEK 28.57m |
| Revenue (TTM) | SEK 3.01m |
6.4x
P/S Ratio-0.7x
P/E RatioIs CMH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CMH income statement (TTM) | |
|---|---|
| Revenue | SEK 3.01m |
| Cost of Revenue | SEK 758.59k |
| Gross Profit | SEK 2.25m |
| Other Expenses | SEK 30.82m |
| Earnings | -SEK 28.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 28, 2025
| Earnings per share (EPS) | -29.14 |
| Gross Margin | 74.78% |
| Net Profit Margin | -949.71% |
| Debt/Equity Ratio | 0% |
How did CMH perform over the long term?
See historical performance and comparison